Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma and Hodgkin's Disease
Trial statusRecruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18+
SponsorStanford University
About this trial
The purpose of this study is to characterize the molecular and cell biology of the tumor cells in lymphoma.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Diagnosis of Hodgkin's disease or non-Hodgkin's lymphoma, any cellular classification, any stage, any grade.
Adult or pediatric patients receiving lymph node excision for purposes other than cancer therapy (i.e. tonsillectomy, sleep apnea).
A routine procedure for tissue collection is planned.
Ability to understand and the willingness to sign a written informed consent.
Disqualifiers
Patients without NHL or Hodgkin's disease
Trial population
Any type of NHL or Hodgkin's disease.
Trial design
Design model
Cohort
Time perspective
Prospective
Treatments tested in this trial
Not listed
Trial groups
No trial groups listed
Trial outcomes
Primary outcomes
1
Collection of tumor tissue to characterize the molecular and cell biology of tumor cells in lymphoma.
Time frame
The study will continue indefinitely.Sponsors and contacts
Click on the lead sponsor to view all of their trials.
Stanford University
Lead sponsor
The Leukemia and Lymphoma Society
Collaborator
Biospect Inc
Collaborator
Source ClinicalTrials.gov